Literature DB >> 23102218

A mitochondria-targeted macrocyclic Mn(II) superoxide dismutase mimetic.

Geoffrey F Kelso1, Andrej Maroz, Helena M Cochemé, Angela Logan, Tracy A Prime, Alexander V Peskin, Christine C Winterbourn, Andrew M James, Meredith F Ross, Sally Brooker, Carolyn M Porteous, Robert F Anderson, Michael P Murphy, Robin A J Smith.   

Abstract

Superoxide (O(2)(·-)) is the proximal mitochondrial reactive oxygen species underlying pathology and redox signaling. This central role prioritizes development of a mitochondria-targeted reagent selective for controlling O(2)(·-). We have conjugated a mitochondria-targeting triphenylphosphonium (TPP) cation to a O(2)(·-)-selective pentaaza macrocyclic Mn(II) superoxide dismutase (SOD) mimetic to make MitoSOD, a mitochondria-targeted SOD mimetic. MitoSOD showed rapid and extensive membrane potential-dependent uptake into mitochondria without loss of Mn and retained SOD activity. Pulse radiolysis measurements confirmed that MitoSOD was a very effective catalytic SOD mimetic. MitoSOD also catalyzes the ascorbate-dependent reduction of O(2)(·-). The combination of mitochondrial uptake and O(2)(·-) scavenging by MitoSOD decreased inactivation of the matrix enzyme aconitase caused by O(2)(·-). MitoSOD is an effective mitochondria-targeted macrocyclic SOD mimetic that selectively protects mitochondria from O(2)(·-) damage.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23102218     DOI: 10.1016/j.chembiol.2012.08.005

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  27 in total

Review 1.  Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives.

Authors:  Gantumur Battogtokh; Yeon Su Choi; Dong Seop Kang; Sang Jun Park; Min Suk Shim; Kang Moo Huh; Yong-Yeon Cho; Joo Young Lee; Hye Suk Lee; Han Chang Kang
Journal:  Acta Pharm Sin B       Date:  2018-05-18       Impact factor: 11.413

Review 2.  Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention.

Authors:  Atefeh Jafari; Hossein Khalili; Simin Dashti-Khavidaki
Journal:  Eur J Clin Pharmacol       Date:  2014-06-25       Impact factor: 2.953

3.  AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.

Authors:  Bartosz Szczesny; Katalin Módis; Kazunori Yanagi; Ciro Coletta; Sophie Le Trionnaire; Alexis Perry; Mark E Wood; Matthew Whiteman; Csaba Szabo
Journal:  Nitric Oxide       Date:  2014-04-19       Impact factor: 4.427

Review 4.  Targeted nanoparticles in mitochondrial medicine.

Authors:  Rakesh K Pathak; Nagesh Kolishetti; Shanta Dhar
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-10-27

Review 5.  Mitochondria-targeted agents: Future perspectives of mitochondrial pharmaceutics in cardiovascular diseases.

Authors:  Thekkuttuparambil Ananthanarayanan Ajith; Thankamani Gopinathan Jayakumar
Journal:  World J Cardiol       Date:  2014-10-26

Review 6.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Authors:  Jacek Zielonka; Joy Joseph; Adam Sikora; Micael Hardy; Olivier Ouari; Jeannette Vasquez-Vivar; Gang Cheng; Marcos Lopez; Balaraman Kalyanaraman
Journal:  Chem Rev       Date:  2017-06-27       Impact factor: 60.622

7.  Insights on Targeting Small Molecules to the Mitochondrial Matrix and the Preparation of MitoB and MitoP as Exomarkers of Mitochondrial Hydrogen Peroxide.

Authors:  Andrew G Cairns; Stephen J McQuaker; Michael P Murphy; Richard C Hartley
Journal:  Methods Mol Biol       Date:  2021

8.  Controlling radicals in the powerhouse: development of MitoSOD.

Authors:  Tanecia Mitchell; Balu K Chacko; Victor Darley-Usmar
Journal:  Chem Biol       Date:  2012-10-26

Review 9.  Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes.

Authors:  Huajun Jin; Arthi Kanthasamy; Anamitra Ghosh; Vellareddy Anantharam; Balaraman Kalyanaraman; Anumantha G Kanthasamy
Journal:  Biochim Biophys Acta       Date:  2013-09-20

Review 10.  New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases.

Authors:  Sanda Win; Tin Aung Than; Jun Zhang; Christina Oo; Robert Win Maw Min; Neil Kaplowitz
Journal:  Hepatology       Date:  2018-04-06       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.